Article content material
- With its focused multimodal method, NeuroAiD™II affords a broad vary of therapeutic advantages to TBI sufferers.
- NeuroAiD™II was well-tolerated by TBI sufferers with a beneficial security profile.
SINGAPORE, Dec. 04, 2023 (GLOBE NEWSWIRE) — Moleac introduced promising outcomes from the SAMURAI double-blind research in sufferers with gentle traumatic mind harm (mTBI) receiving a 6-month course of NeuroAiD™II. Within the research, the NeuroAiD™II group confirmed vital enchancment of their post-concussion signs, high quality of life and temper, in comparison with these within the placebo group.
Commercial 2
Article content material
Article content material
Offered by Professor Valery Feigin on the World Congress of Neurology, final October in Montreal, these outcomes increase the checklist of therapeutic advantages of NeuroAiD™II noticed in earlier scientific trials carried out on TBI sufferers, and ensure its beneficial security profile1, 2, 3.
Within the SAMURAI research, mTBI sufferers underwent a sequence of exams assessing numerous varieties of impairments and their restoration over time. For cognition, a self-assessment was achieved by the affected person utilizing a computerized scale, the Computerized Neurocognitive Evaluation-Important Indicators (CNS-VS). For post-concussion signs, high quality of life and temper, the exams had been carried out by the investigators utilizing 3 totally different scales: the Rivermead Put up-Concussion Signs Questionnaire (RPQ), the High quality of Life after Mind Damage (QOLIBRI) scale, and the Hospital Nervousness and Despair Scale (HADS) respectively.
Whereas the development of CNS-VS self-assessment rating was not totally different between teams on the 6-month and 9-month time factors with a shocking enchancment within the placebo group, the assessments carried out by investigators confirmed extremely statistically vital advantages of NeuroAiD™II over placebo at each 6-month and 9-month time level, and on the three scales. These optimistic outcomes replicate the sturdy advantages supplied by NeuroAiD™II, even after remedy discontinuation.
High Tales
Article content material
Commercial 3
Article content material
“Persistent signs following a TBI can severely have an effect on a affected person’s day-to-day life. Following the pilot research BRAINS1, we’re additional inspired by SAMURAI, illustrating the large spectrum of advantages supplied by NeuroAiD™II in serving to sufferers to attain a holistic restoration within the bodily, cognitive and emotional features,” stated David Picard, CEO of Moleac.
Professor Feigin added, “The trial confirmed that though NeuroAid didn’t considerably improved cognitive functioning in publish gentle traumatic mind harm people, it considerably decreased numerous different complaints related to the harm (lightheadedness, complications, dizziness, anxiousness, melancholy and so on) and improved total health-related high quality of life after mTBI. I’ve no doubts that, when indicated, tens of millions of people with mTBI may benefit from utilizing NeuroAid to alleviate their post-injury signs.”
TBI is an harm attributable to a mechanical impression on the mind or cranium or by the penetration of objects into the cranium. Harm and dying of mind cells usually result in neurological and cognitive deficits. The worldwide incidence of TBI is about 50 to 60 million new occasions annually, with mTBI representing greater than 90% of all TBI4. After one yr, 20% to over 30% of mTBI sufferers proceed to expertise clinically vital sequelae and over 80% stay symptomatic5. Persistent deficits can extremely have an effect on one’s potential to stay independently5. Furthermore, these bodily, cognitive, and emotional signs could persist for a very long time6,7. This represents an pressing want for TBI remedy to not solely deal with bodily signs however to positively impression the psychological and emotional well-being of the sufferers.
Commercial 4
Article content material
Dr. Sylvain Durrleman, Head of Medical Affairs at Moleac, commented, “Restoration from TBI is complicated and multidimensional. With its multimodal mechanism of motion, NeuroAiD™II is well-suited for TBI restoration, exhibiting optimistic scientific impacts on bodily signs and necessary parameters of the standard of life.”
On how the outcomes could contribute to scientific follow within the illness space, Dr. Durrleman added, “We hope the outcomes are significant to each healthcare practitionners and sufferers, additional demonstrating the advantage of NeuroAiD™II in selling restoration processes.”
For extra data, please go to www.neuroaid.com.
About NeuroAiD™II
NeuroAiD™II is a scientifically-researched formulation containing 9 pure natural elements, really helpful for sufferers with established deficits to spice up their restoration after a traumatic mind harm.
About Moleac
Moleac is a biopharmaceutical firm dedicated to serving to sufferers and households reconnect with their lives. Headquartered in Singapore, we’re devoted to growing scientifically confirmed progressive formulations that bridge therapeutic gaps and tackle unmet wants of sufferers with neurological circumstances comparable to stroke, traumatic mind accidents and dementia.
Moleac’s flagship product NeuroAiD™II advantages greater than 40,000 sufferers in over 35 international locations yearly.
For extra data, please go to www.moleac.com.
Contact Particulars
Title of Press Contact: Clement Dif
Cellphone: +65 6211 3710
Electronic mail: communication@moleac.com
Article content material